Unexplained weight loss (UWL), clinically defined as a loss of more than 5% of body weight within a 6-12 month period without a known cause, can be a diagnostic challenge for physicians. It is often a manifestation of underlying serious conditions, requiring a comprehensive and systematic approach for effective management.
A thorough history taking and physical examination is the cornerstone of the initial evaluation. It is crucial to identify any changes in appetite, dietary habits, psychiatric symptoms, or medications that may contribute to weight loss. The physical examination should focus on signs of malnutrition, wasting syndromes, and systemic diseases.
Basic laboratory tests, including complete blood count, comprehensive metabolic panel, thyroid function tests, and inflammatory markers, are recommended in the initial workup. If these tests are inconclusive, advanced diagnostic tools such as imaging studies, endoscopies, or biopsies may be necessary.
Once the underlying cause is identified, management should be condition-specific and patient-centered. In cases where no cause is found, symptomatic management with nutritional support and appetite stimulants can be beneficial. Regular follow-up is essential to monitor the patient's progress and adjust treatment plans accordingly.
Unexplained weight loss is a complex clinical problem that requires a comprehensive approach for effective evaluation and management. A systematic and methodical approach can help identify the underlying cause, enabling appropriate, timely interventions. It is essential to remember that despite exhaustive investigations, a cause may not always be found, and symptomatic management becomes crucial.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation